ANDA 40415, held by Aurobindo Pharma USA. Warfarin Sodium.
As of Nov 16, 2026, ANDA 40415 (Warfarin Sodium), held by Aurobindo Pharma USA, was first approved by FDA on Sep 27, 2004, with 7 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 27, 2004 | Original application | Approved | None posted |
| Warfarin Sodium1MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium2MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium2.5MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium3MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium4MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium5MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium6MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium7.5MG · tablet;oral | Warfarin Sodium | Discontinued |
| Warfarin Sodium10MG · tablet;oral | Warfarin Sodium | Discontinued |
| Feb 28, 2012 | Supplement 13Labeling | Approved | None posted |
| Nov 22, 2011 | Supplement 11Labeling | Approved | None posted |
| Feb 8, 2011 | Supplement 10Labeling | Approved | None posted |
| Aug 4, 2010 | Supplement 9Labeling | Approved | None posted |
| Nov 16, 2009 | Supplement 8Labeling | Approved | None posted |
| Jan 22, 2009 | Supplement 6Labeling | Approved | None posted |
| Jan 9, 2007 | Supplement 3Labeling | Approved | |
| Sep 27, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters